Quarterly Result27 Jul 2026, 07:30 pm
Balaji Amines Q1FY27: Revenue ₹461 Cr, EBITDA ₹121 Cr, PAT ₹78 Cr
AI Summary
Balaji Amines Limited announced its unaudited financial results for the quarter ended June 30, 2026 (Q1FY27). Consolidated Revenue from Operations stood at ₹461 crore, up from ₹403 crore in Q4FY26. EBITDA was ₹121 crore, with a 26% margin, and Net Profit (PAT) was ₹78 crore, with a 17% margin. Diluted EPS for Q1FY27 was ₹23.13. The company maintained stable operational performance despite lower volumes compared to Q1FY26. Balaji Amines also highlighted the successful commissioning of its 100,000 TPA Dimethyl Ether (DME) plant and ongoing expansion projects for N-Methyl Morpholine (NMM), Acetonitrile (ACN), and Balaji Speciality Chemicals, all targeted for commissioning in FY27.
Key Highlights
- Q1FY27 Consolidated Revenue ₹461 Cr, up from Q4FY26.
- EBITDA ₹121 Cr and PAT ₹78 Cr with strong margins.
- DME plant commissioned; NMM and ACN expansion planned for FY27.
- Balaji Speciality Chemicals' ₹750 Cr expansion progressing for FY27.
- Company reports strong start to FY27 with improved demand.
Price Impact
More from BALAMINES